3rd Quarter - Report
COVINGTON & BURLING LLP for FABRE-KRAMER PHARMACEUTICALS, INC
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Policy regarding demonstration of effectiveness for new drug approvals. 21st Century Cures (HR 6); No Senate Bill number yet
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| MICHAEL S LABSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.